Linked Life Data

17310329

Source:http://linkedlifedata.com/resource/pubmed/id/17310329

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2007-3-20
pubmed:abstractText
In MSUD, dietary treatment aims at the protection of the brain from functional disturbances and structural damage by keeping the branched-chain amino acids in plasma permanently in the near-normal range. Unfortunately, delay in effective treatment of the neonatal manifestation and poor long-term metabolic control are common in MSUD patients, leading to impaired cognitive outcome. Some studies have analysed cognitive capacity but only few data are available on social status (educational qualification, interpersonal relationships, lifestyle) in adult patients, which is one measure for the success of treatment. Aim: In this study we analysed sociodemographic data of 22 adult patients suffering from classic or very severe variant MSUD in comparison with data on an age-matched control collective of the population of Germany.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
1573-2665
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
30
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
264
pubmed:meshHeading
pubmed:year
2007
pubmed:articleTitle
Social outcome in adults with maple syrup urine disease (MSUD).
pubmed:affiliation
Department of General Pediatrics, Heinrich Heine University, Düsseldorf, Germany. simon@med.uni-duesseldorf.de
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't